Skip to main content
Log in

Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

To investigate the compatibility between hard gelatin and HPMC capsules with a range of different isotropic lipid based formulations containing multiple excipients.

Methods

The miscibility was investigated for 350 systems applying five different oils (Labrafac ™ lipophile WL1349, Maisine® CC, Captex 300 EP/NF, olive oil, and Capmul MCM EP/NF), five different surfactans (Labrasol ® ALF, Labrafil M 2125 CS, Kolliphor ® ELP, Kolliphor ® HS 15, Tween 80) and three different cosolvents (propylene glycol, polyethylene glycol 400, and Transcutol ® HP). For the isotropic systems capsule compatibility was investigated in both gelatin and HPMC capsules at 25°C at 40% and 60% relative humidity by examining physical damages to the capsules and weight changes after storage.

Results

The miscibility of lipid based vehicles was best when the formulation contained monoglycerides and surfactants with a hydrophilic–lipophilic balance value <12. Gelatin capsules in general resulted in a better compatibility when compared to HPMC capsules for the evaluated formulations. Addition of water to the formulation improved the capsule compatibility for both capsule types. The expected capsule mass change could partly be predicted in binary systems using the provided data of the single excipients weighted for its formulation proportion.

Conclusions

The capsule compatibility was driven by the components incorporated into the formulations, where more was compatible with gelatin than HPMC capsules. Prediction of the mass change from individual excipient contributions can provide a good first estimate if a vehicle is compatible with a capsule, however, this needs to be proved experimentally.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ditzinger F, Price DJ, Ilie AR, Köhl NJ, Jankovic S, Tsakiridou G, et al. Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review. J Pharm Pharmacol. 2019;71:464–82.

    Article  CAS  Google Scholar 

  2. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278–87.

    Article  CAS  Google Scholar 

  3. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60:734–46.

    Article  CAS  Google Scholar 

  4. Gullapalli RP, Mazzitelli CL. Gelatin and non-gelatin capsule dosage forms. J Pharm Sci. 2017;106:1453–65.

    Article  CAS  Google Scholar 

  5. Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm. 2017;43:1743–58.

    Article  CAS  Google Scholar 

  6. Cole ET. Liquid filled and sealed hard gelatin capsules. Bull Tech Gattefossé. 1999;92:67–77.

    CAS  Google Scholar 

  7. Cole ET, Cadé D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60:747–56.

    Article  CAS  Google Scholar 

  8. Reich G. Formulation and physical properties of soft capsules. In: Podczeck F, Jones BE, editors. Pharmaceutical Capsules. London: Pharmaceutical Press; 2004. p. 201–12.

    Google Scholar 

  9. Machado AH, Kokubo T, Dujovny G, Jones B, Scialdone C, Bravo R, et al. A microstructural study of water effects in lipid-based pharmaceutical formulations for liquid filling of capsules. Eur J Pharm Sci. 2016;90:64–75.

    Article  CAS  Google Scholar 

  10. Chen FJ, Etzler FM, Ubben J, Birch A, Zhong L, Schwabe R, et al. Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules. J Pharm Sci. 2010;99:128–41.

    Article  CAS  Google Scholar 

  11. Kesisoglou F, Panmai S, Wu Y. Nanosizing--oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631–44.

    Article  CAS  Google Scholar 

  12. Djekic L, Jankovic J, Čalija B, Primorac M. Development of semisolid self-microemulsifying drug delivery systems (SMEDDSs) filled in hard capsules for oral delivery of aciclovir. Int J Pharm. 2017;528:372–80.

    Article  CAS  Google Scholar 

  13. Digenis GA, Gold TB, Shah VP. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci. 1994;83:915–21.

    Article  CAS  Google Scholar 

  14. Brown J, Madit N, Cole ET, Wilding IR, Cadé D. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules. Pharm Res. 1998;15:1026–30.

    Article  CAS  Google Scholar 

  15. Kontny MJ, Mulski CA. Gelatin capsule brittleness as a function of relative humidity at room temperature. Int J Pharm. 1989;54:79–85.

    Article  CAS  Google Scholar 

  16. Liebowitz SM, Vadino WA, Ambrosio TJ. Determination of hard gelatin capsule brittlenss using a motorized compression test stand. Drug Dev Ind Pharm. 1990;16:995–1010.

    Article  CAS  Google Scholar 

  17. Kuentz M. Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects. J Drug Del Sci Tech. 2011;21:17–26.

    Article  CAS  Google Scholar 

  18. Honkanen O, Laaksonen P, Marvola J, Eerikäinen S, Tuominen R, Marvola M. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations. Eur J Pharm Sci. 2002;15:479–88. Erratum in: Eur J Pharm Sci 2002;17:105.

  19. Ku MS, Lu Q, Li W, Chen Y. Performance qualification of a new hypromellose capsule: part II. Disintegration and dissolution comparison between two types of hypromellose capsules. Int J Pharm. 2011;416:16–24.

    Article  CAS  Google Scholar 

  20. Grüne L, Bunjes H. Suitability of phosphatidylcholine-based formulations for liquid filling in hard capsules. Eur J Pharm Sci. 2020;153:105470.

    Article  Google Scholar 

  21. https://www.gattefosse.com/pharmaceuticals-products/labrafac-lipophile-wl-1349/, Accessed 14 May 2021.

  22. https://www.gattefosse.com/pharmaceuticals-products/maisine-cc/, Accessed 14 May 2021.

  23. https://www.gattefosse.com/pharmaceuticals-products/labrasol-alf/, Accessed 14 May 2021.

  24. https://www.gattefosse.com/pharmaceuticals-products/labrafil-m-2125-cs/, Accessed 14 May 2021.

  25. https://pharmaceutical.basf.com/global/en/drug-formulation/downloads.html#%7B%220%22%3A%5B%5B%22productId%22%2C%5B%22%2F8801044758670%22%5D%5D%2C%5B%22facet%3AcontentLanguage%22%2C%5B%22en%22%5D%5D%5D%2C%22page%22%3A%220%22%2C%22id%22%3A%22result-0%22%7D, Accessed 14 May 2021.

  26. https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma-Aldrich/Product_Information_Sheet/p8074pis.pdf, Accessed 14 May 2021.

  27. Kuentz M, Röthlisberger D. Determination of the optimal amount of water in liquid-fill masses for hard gelatin capsules by means of texture analysis and experimental design. Int J Pharm. 2002;236:145–52.

    Article  CAS  Google Scholar 

  28. Cadé D, Madit N. Liquid filling in hard gelatin capsules - preliminary steps. Capsugel 1996.

  29. Reichert CL, Salminen H, Leuenberger BH, Weiss J. Influence of heat on miscibility of Quillaja saponins in mixtures with a co-surfactant. Food Res Int. 2016;88:16–23.

    Article  CAS  Google Scholar 

  30. Damian F, Harati M, Schwartzenhauer J, Van Cauwenberghe O, Wettig SD. Challenges of dissolution methods development for soft gelatin capsules. Pharmaceutics. 2021;13:214.

    Article  Google Scholar 

  31. https://www.capsugel.com/knowledge-center/vcapsplus-faq-moisture-and-storage-conditions#:~:text=Recommended%20storage%20conditions%20for%20both%20gelatin%20and%20Capsugel%C2%AE,within%E2%80%94suitable%20in%20RH%20conditions%20of%2010%20to%2070%25, Accessed 18 May 2021.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to René Holm.

Ethics declarations

Disclosures of Financial Interest

The authors declare no financial interest

Additional information

Niklas J. Koehl and Sanket Shah contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(PDF 4064 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koehl, N.J., Shah, S., Tenekam, I.D. et al. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study. Pharm Res 38, 1439–1454 (2021). https://doi.org/10.1007/s11095-021-03088-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-021-03088-8

KEY WORDS

Navigation